Legis Daily

Long-Term Care Pharmacy Definition Act of 2021

USA117th CongressHR-5632| House 
| Updated: 10/20/2021
Kurt Schrader

Kurt Schrader

Democratic Representative

Oregon

Cosponsors (19)
Diana Harshbarger (Republican)Adrian Smith (Republican)Tom O'Halleran (Democratic)Markwayne Mullin (Republican)Jake LaTurner (Republican)Brett Guthrie (Republican)Rick W. Allen (Republican)Earl L. "Buddy" Carter (Republican)Billy Long (Republican)H. Morgan Griffith (Republican)Don Bacon (Republican)G. K. Butterfield (Democratic)Glenn Grothman (Republican)John H. Rutherford (Republican)Lucy McBath (Democratic)James Comer (Republican)Sharice Davids (Democratic)Bradley Scott Schneider (Democratic)Michael Guest (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Long-Term Care Pharmacy Definition Act of 2021 This bill establishes a statutory definition for long-term care pharmacy under the Medicare prescription drug benefit. Currently, there is no statutory definition. Regulations from the Centers for Medicare & Medicaid Services (CMS) define a long-term care pharmacy as a pharmacy that is owned by or under contract with a long-term care facility to provide prescription drugs to the facility's residents. Additional requirements are set out in CMS guidance relating to the Medicare prescription drug benefit; pharmacies are also subject to regulations and guidance from other agencies (e.g., packaging requirements from the Food and Drug Administration). The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-7757
Long-Term Care Pharmacy Definition Act of 2020
May 12, 2021

Latest Companion Bill Action

S 117-1574
Introduced in Senate
Oct 19, 2021
Introduced in House
Oct 19, 2021
Referred to the Subcommittee on Health.
Oct 19, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 20, 2021
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-7757
    Long-Term Care Pharmacy Definition Act of 2020


  • May 12, 2021

    Latest Companion Bill Action

    S 117-1574
    Introduced in Senate


  • October 19, 2021
    Introduced in House


  • October 19, 2021
    Referred to the Subcommittee on Health.


  • October 19, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • October 20, 2021
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 117-1574: Long-Term Care Pharmacy Definition Act of 2021

Long-Term Care Pharmacy Definition Act of 2021

USA117th CongressHR-5632| House 
| Updated: 10/20/2021
Long-Term Care Pharmacy Definition Act of 2021 This bill establishes a statutory definition for long-term care pharmacy under the Medicare prescription drug benefit. Currently, there is no statutory definition. Regulations from the Centers for Medicare & Medicaid Services (CMS) define a long-term care pharmacy as a pharmacy that is owned by or under contract with a long-term care facility to provide prescription drugs to the facility's residents. Additional requirements are set out in CMS guidance relating to the Medicare prescription drug benefit; pharmacies are also subject to regulations and guidance from other agencies (e.g., packaging requirements from the Food and Drug Administration). The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-7757
Long-Term Care Pharmacy Definition Act of 2020
May 12, 2021

Latest Companion Bill Action

S 117-1574
Introduced in Senate
Oct 19, 2021
Introduced in House
Oct 19, 2021
Referred to the Subcommittee on Health.
Oct 19, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 20, 2021
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-7757
    Long-Term Care Pharmacy Definition Act of 2020


  • May 12, 2021

    Latest Companion Bill Action

    S 117-1574
    Introduced in Senate


  • October 19, 2021
    Introduced in House


  • October 19, 2021
    Referred to the Subcommittee on Health.


  • October 19, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • October 20, 2021
    Referred to the Subcommittee on Health.
Kurt Schrader

Kurt Schrader

Democratic Representative

Oregon

Cosponsors (19)
Diana Harshbarger (Republican)Adrian Smith (Republican)Tom O'Halleran (Democratic)Markwayne Mullin (Republican)Jake LaTurner (Republican)Brett Guthrie (Republican)Rick W. Allen (Republican)Earl L. "Buddy" Carter (Republican)Billy Long (Republican)H. Morgan Griffith (Republican)Don Bacon (Republican)G. K. Butterfield (Democratic)Glenn Grothman (Republican)John H. Rutherford (Republican)Lucy McBath (Democratic)James Comer (Republican)Sharice Davids (Democratic)Bradley Scott Schneider (Democratic)Michael Guest (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 117-1574: Long-Term Care Pharmacy Definition Act of 2021
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted